Atopic Dermatitis (AD) is a chronic inflammatory skin disease affecting approximately 230 million people worldwide, characterized by skin barrier dysfunction and an imbalance in the skin microbiota. A major driver of AD progression is the overgrowth of Staphylococcus aureus (SA), which forms resilient biofilms that exacerbate inflammation and resist conventional treatments. While Staphylococcus epidermidis (SE) is a common commensal, its overgrowth during AD flares can also contribute to inflammation. To address this, researchers investigated hop extracts (Humulus lupulus) as a potential solution. Hops are rich in bioactive compounds like humulone, lupulone, and xanthohumol, which possess known antimicrobial and anti-inflammatory properties. This study specifically explores using brewing industry waste (trub) to source these compounds, offering a sustainable, circular economy approach to developing natural dermatological treatments.
Methods
Researchers performed solid-liquid extraction using 96% ethanol and a mixing extruder to recover bioactive compounds from craft beer brewing trub. The resulting extracts were chemically characterized via HPLC and verified for microbiological quality according to European Pharmacopoeia standards. The antimicrobial efficacy was evaluated by determining the Minimum Inhibitory Concentration (MIC) and Minimum Lethal Concentration (MLC) against SA and SE strains. Finally, the extract’s ability to prevent and disrupt bacterial biofilms was quantified using crystal violet staining and statistical analysis.
Key Findings
- Rich Bioactive Composition: The ethanolic extract was highly enriched with xanthohumol (~31.5%) and colupulone (~46.2%), both of which are potent antimicrobial agents.
- Selective Antimicrobial Activity: The extract demonstrated a bactericidal effect against S. aureus (MLC 0.515%) and a bacteriostatic effect against S. epidermidis (MLC 1.030%).
- Effective Biofilm Inhibition: SA was found to be more susceptible to the extract, with biofilm formation significantly inhibited at 0.5× MIC, whereas SE required 5× MIC for similar inhibition.
- Biofilm Disruption: The extract successfully reduced pre-formed biofilms; SA and mixed-species biofilms were disrupted at 2× MIC, while SE biofilms required a higher concentration of 5× MIC.
- Safety and Quality: The extract complied with microbiological quality requirements for cutaneous use, showing no bacterial or fungal growth.
The novelty of this research lies in the successful valorization of brewing waste to create a high-value bioactive ingredient capable of selectively targeting pathogens while preserving commensal activity. By demonstrating that hop-derived compounds can disrupt the virulent biofilms of S. aureus, this study establishes a sustainable and naturally derived strategy for restoring microbial balance in AD patients. Future implications include the integration of these extracts into cosmetic and pharmaceutical formulations; however, further research using advanced human skin models is necessary to confirm long-term safety and clinical efficacy.
Link to the study: https://www.mdpi.com/2079-9284/13/2/62
